Lung Transplant Foundation is located in Cary, NC. The organization was established in 2009. According to its NTEE Classification (G45) the organization is classified as: Lung Diseases, under the broad grouping of Voluntary Health Associations & Medical Disciplines and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Lung Transplant Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2023, Lung Transplant Foundation generated $122.0k in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 1.6% each year. All expenses for the organization totaled $232.3k during the year ending 09/2023. You can explore the organizations financials more deeply in the financial statements section below.
Form
990EZ
Mission & Program ActivityExcerpts From the 990EZ Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE LUNG TRANSPLANT FOUNDATION (LTF) IS THE ONLY MAJOR NON-PROFIT ORGANIZATION DEDICATED TO SUPPORTING RESEARCH INTO POST-TRANSPLANT REJECTION. THE ORGANIZATION HELPS RAISE AWARENESS ABOUT ORGAN DONATION, SUPPORTS RESEARCH TO IMPROVE LONG-TERM OUTCOMES AND PROVIDES MENTORING SERVICES FOR LUNG TRANSPLANT RECIPIENTS AND THEIR FAMILIES. OUR GOAL IS TO CREATE A WORLD WHERE ALL LUNG TRANSPLANT PATIENTS LIVE LONG, HEALTHY LIVES.
Describe the Organization's Program Activity:
Part 3
AWARENESS & CURRENT EVENTS: THE LUNG TRANSPLANT FOUNDATION WORKS TO ADVOCATE FOR CONSTRUCTIVE PUBLIC POLICIES THAT SUPPORT LUNG TRANSPLANT PATIENTS AND THEIR FAMILIES. WE STRIVE TO BRING THE ISSUES OF POST-TRANSPLANT REJECTION TO THE FOREFRONT THROUGH NETWORKING AND ACTIVISM WITH GOVERNMENT AGENCIES, PHARMACEUTICAL AND MEDICAL TECHNOLOGY COMPANIES, AND THE MEDICAL COMMUNITY ON BEHALF OF THE LUNG TRANSPLANT POPULATION.
RESEARCH: RESEARCH INTO LUNG TRANSPLANT REJECTION LACKS SIGNIFICANT FINANCIAL SUPPORT FROM THE GOVERNMENT AND PHARMACEUTICAL COMPANIES. OUR GOAL IS TO DEVELOP, INITIATE, AND SUPPORT RESEARCH EFFORTS ON ISSUES SURROUNDING LUNG TRANSPLANTATION, TO FIND TREATMENTS, AND ULTIMATELY, A SOLUTION, FOR CHRONIC REJECTION.
PATIENT MENTORSHIP: THE JOSEPH J. CARTER MENTORSHIP PROGRAM IS A SERVICE AVAILABLE TO LUNG TRANSPLANT PATIENTS AND CAREGIVERS NATIONWIDE, DEVELOPED BY LUNG TRANSPLANT PATIENTS AND CAREGIVERS. A WELL-INFORMED LUNG TRANSPLANT PATIENT AND CAREGIVER CONTRIBUTES TO OVERALL RECOVERY SUCCESS.
Name (title) | Role | Hours | Compensation |
---|---|---|---|
Harry Collins President | 8 | $0 | |
Ellen Goldstein Secretary | 20 | $0 | |
Tim Berger Director | 8 | $0 | |
Brian Bennett Treasurer | 1.5 | $0 | |
Paul Sun Director | 1 | $0 | |
Kelly Dagger Director | 10 | $0 |
Statement of Revenue | |
---|---|
Total Revenue from Contributions, Gifts, Grants & Similar | $116,893 |
Total Program Service Revenue | $5,000 |
Membership dues | $0 |
Investment income | $80 |
Gain or Loss | $0 |
Net Income from Gaming & Fundraising | $0 |
Other Revenue | $0 |
Total Revenue | $121,973 |
Statement of Expenses | |
---|---|
Grants and similar amounts paid | $0 |
Benefits paid to or for members | $0 |
Salaries, other compensation, and employee benefits | $129,934 |
Professional fees and other payments to independent contractors | $41,274 |
Occupancy, rent, utilities, and maintenance | $979 |
Printing, publications, postage, and shipping | $699 |
Other expenses | $59,374 |
Total expenses | $232,260 |
Balance Sheet | |
---|---|
Cash, savings, and investments | $137,490 |
Other assets | $0 |
Total assets | $147,490 |
Total liabilities | $6,594 |
Net assets or fund balances | $140,896 |
Over the last fiscal year, Lung Transplant Foundation has awarded $74,725 in support to 2 organizations.
Grant Recipient | Amount |
---|---|
DUKE UNIVERSITY PURPOSE: RESEARCH TO PREVENT AND TREAT BROCHICAL OBLITERANS SYNDROME/DISEASE | $60,000 |
THE REPAIRION GROUP PURPOSE: EARLY STAGE DEVELOPMENT OF DRUG COMPOUND TO IMPROVE OUTCOMES FOR LUNG TRANSPLANT RECIPIENTS | $14,725 |
Organization Name | Assets | Revenue |
---|---|---|
National Tuberculosis Controllers Association Inc Alpharetta, GA | $461,904 | $915,541 |
Tobacconists Association Of America Ltd Conyers, GA | $1,610,420 | $941,610 |
Tobacco Associates Incorporated Raleigh, NC | $1,036,459 | $614,120 |
Lung Transplant Foundation Cary, NC | $147,490 | $0 |
South Carolina Society For Respiratory Care Columbia, SC | $157,319 | $0 |
Specialty Tobacco Council Inc Winston Salem, NC | $24,254 | $106,800 |
Pediatric Acute Lung Injury And Sepsis Investigators Network Burlington, NC | $80,894 | $165,896 |
Richland Tuberculosis Association Columbia, SC | $580,594 | $1,992 |
Tobacco Assn Of U S Inc Danville, VA | $29,782 | $0 |
Live Fearlessly Foundation Wilmington, NC | $23,792 | $25,895 |
Join The Fight Inc Atlanta, GA | $0 | $0 |